Sadaf Faisal, senior director of professional affairs at the Canadian Pharmacists Association, said the codeine-containing medications such as Tylenol 3 are back in stock. Supply is still limited for ...
Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...
In late August, Kyle Kennedy — from Liverpool, England — started experiencing pain and swelling in his neck, as well as night ...
The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...
Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...
For the past several months, Camilla has often worn a pinky ring on her left hand. Little is known about the piece, but it ...
Hospitals across Baltimore are seeing an increase in patients but cannot point to a particular illness as the cause.
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...
Pharmaceutical Technology on MSN
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...
Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling Palantir - whose stock has more than doubled this year on AI excitement and ...
Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results